Acotec Scientific Holdings Limited (HKG:6669)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
12.05
+0.81 (7.21%)
Mar 10, 2026, 3:33 PM HKT
81.48%
Market Cap 3.52B
Revenue (ttm) 649.64M
Net Income (ttm) 110.56M
Shares Out 313.39M
EPS (ttm) 0.36
PE Ratio 31.06
Forward PE 27.58
Dividend n/a
Ex-Dividend Date n/a
Volume 283,000
Average Volume 325,230
Open 11.25
Previous Close 11.24
Day's Range 11.24 - 12.19
52-Week Range 6.29 - 15.47
Beta 0.17
RSI 42.48
Earnings Date Mar 25, 2026

About HKG:6669

Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally. The company’s products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease with a vascular interventional approach; and AcoArt Tulip & Litos, a paclitaxel coated DCB used to prevent stenosis or occlusion in below-theknee arteries ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2011
Employees 645
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6669
Full Company Profile

Financial Performance

In 2024, HKG:6669's revenue was 533.99 million, an increase of 12.69% compared to the previous year's 473.85 million. Earnings were 52.28 million, an increase of 260.88%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.